| Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members BP Yawn, GR Buchanan, AN Afenyi-Annan, SK Ballas, KL Hassell, ... Jama 312 (10), 1033-1048, 2014 | 1468 | 2014 |
| Mortality rates and age at death from sickle cell disease: US, 1979–2005 S Lanzkron, CP Carroll, C Haywood Jr Public health reports 128 (2), 110-116, 2013 | 476 | 2013 |
| A Phase 3 Trial of l-Glutamine in Sickle Cell Disease Y Niihara, ST Miller, J Kanter, S Lanzkron, WR Smith, LL Hsu, ... New England Journal of Medicine 379 (3), 226-235, 2018 | 422 | 2018 |
| HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease J Bolaños-Meade, EJ Fuchs, L Luznik, SM Lanzkron, CJ Gamper, ... Blood, The Journal of the American Society of Hematology 120 (22), 4285-4291, 2012 | 411 | 2012 |
| Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease S Lanzkron, JJ Strouse, R Wilson, MC Beach, C Haywood, HS Park, ... Annals of internal medicine 148 (12), 939-955, 2008 | 319 | 2008 |
| Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children JJ Strouse, S Lanzkron, MC Beach, C Haywood, H Park, C Witkop, ... Pediatrics 122 (6), 1332-1342, 2008 | 241 | 2008 |
| Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity RF Machado, RJ Barst, NA Yovetich, KL Hassell, GJ Kato, VR Gordeuk, ... Blood, The Journal of the American Society of Hematology 118 (4), 855-864, 2011 | 235 | 2011 |
| Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial MT Gladwin, GJ Kato, D Weiner, OC Onyekwere, C Dampier, L Hsu, ... Jama 305 (9), 893-902, 2011 | 235 | 2011 |
| Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use MJ Telen, T Wun, TL McCavit, LM De Castro, L Krishnamurti, S Lanzkron, ... Blood, The Journal of the American Society of Hematology 125 (17), 2656-2664, 2015 | 214 | 2015 |
| Do words matter? Stigmatizing language and the transmission of bias in the medical record A P Goddu, KJ O’Conor, S Lanzkron, MO Saheed, S Saha, ME Peek, ... Journal of general internal medicine 33, 685-691, 2018 | 202 | 2018 |
| The burden of emergency department use for sickle cell disease: An analysis of the national emergency department sample database S Lanzkron, CP Carroll, C Haywood Jr American journal of hematology 85 (10), 797, 2010 | 200 | 2010 |
| Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans RP Naik, VK Derebail, ME Grams, N Franceschini, PL Auer, GM Peloso, ... Jama 312 (20), 2115-2125, 2014 | 195 | 2014 |
| Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells SM Lanzkron, MI Collector, SJ Sharkis Blood, The Journal of the American Society of Hematology 93 (6), 1916-1921, 1999 | 189 | 1999 |
| The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe M Nouraie, JS Lee, Y Zhang, T Kanias, X Zhao, Z Xiong, TB Oriss, Q Zeng, ... Haematologica 98 (3), 464, 2013 | 180 | 2013 |
| Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication RP Naik, MB Streiff, C Haywood Jr, JA Nelson, S Lanzkron The American journal of medicine 126 (5), 443-449, 2013 | 173 | 2013 |
| Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease D Lubeck, I Agodoa, N Bhakta, M Danese, K Pappu, R Howard, ... JAMA Network Open 2 (11), e1915374-e1915374, 2019 | 171 | 2019 |
| A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease C Haywood Jr, MC Beach, S Lanzkron, JJ Strouse, R Wilson, H Park, ... Journal of the National Medical Association 101 (10), 1022-1033, 2009 | 150 | 2009 |
| Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with … V Sachdev, GJ Kato, JSR Gibbs, RJ Barst, RF Machado, M Nouraie, ... Circulation 124 (13), 1452-1460, 2011 | 147 | 2011 |
| The impact of race and disease on sickle cell patient wait times in the emergency department C Haywood Jr, P Tanabe, R Naik, MC Beach, S Lanzkron The American journal of emergency medicine 31 (4), 651-656, 2013 | 146 | 2013 |
| Hospitalization rates and costs of care of patients with sickle‐cell anemia in the state of Maryland in the era of hydroxyurea S Lanzkron, C Haywood Jr, JB Segal, GJ Dover American journal of hematology 81 (12), 927-932, 2006 | 134 | 2006 |
